Vietnam Companion Animal Osteoarthritis Market Report: Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025-2030

Vietnam Companion Animal Osteoarthritis Market is valued at USD 20 million, driven by rising pet ownership, health awareness, and advanced treatments like NSAIDs and nutraceuticals.

The Vietnam Companion Animal Osteoarthritis Market is valued at USD 20 million, based on a five-year historical analysis and triangulation from the veterinary diagnostics and animal health segments. This growth is primarily driven by increasing pet ownership rates, rising awareness about pet health, and the growing demand for advanced veterinary care. The market has seen a surge in the adoption of innovative treatment options, including nutraceuticals and monoclonal antibody therapies, which cater to the needs of aging pets suffering from osteoarthritis.

Key cities such as Ho Chi Minh City and Hanoi dominate the market due to their high population density and increasing disposable income among pet owners. These urban areas have a well-established network of veterinary clinics and pet specialty stores, facilitating easy access to osteoarthritis treatments. Additionally, the growing trend of pet humanization in these cities has led to a higher demand for premium pet healthcare products.

In 2023, the Vietnamese government implemented regulations to enhance the quality of veterinary services and products. The most relevant binding instrument is the “Law on Animal Health No. 79/2015/QH13,” issued by the National Assembly of Vietnam, which mandates the registration, approval, and quality control of veterinary drugs and biologicals. This law requires all veterinary medicines, including those for companion animals, to undergo safety and efficacy evaluation before approval and market entry, supporting animal health and responsible pet ownership.

Vietnam Companion Animal Osteoarthritis Market Segmentation

By Type:

The market is segmented into various types of treatments for osteoarthritis in companion animals. The subsegments include Non-steroidal anti-inflammatory drugs (NSAIDs), Nutraceuticals (including glucosamine and chondroitin sulphate), Disease-modifying osteoarthritis drugs (DMOADs), Monoclonal antibody therapies (e.g., Librela®, Solensia®), Traditional Vietnamese herbal medicines (e.g., TD0015), Surgical interventions, Rehabilitation therapies, Regenerative medicine (e.g., stem cell therapies), and Others. Among these, NSAIDs and Nutraceuticals are the most widely used due to their effectiveness and availability.

By End-User:

The end-user segmentation includes Veterinary clinics, Pet hospitals, Home care, and Pet owners. Veterinary clinics and pet hospitals are the primary users of osteoarthritis treatments, as they provide direct medical care to pets. Home care is gaining traction as pet owners increasingly seek to manage their pets' health at home, utilizing nutraceuticals and rehabilitation therapies.

Vietnam Companion Animal Osteoarthritis Market Competitive Landscape

The Vietnam Companion Animal Osteoarthritis Market is characterized by a dynamic mix of regional and international players. Leading participants such as Zoetis Inc., Merck Animal Health, Elanco Animal Health, Boehringer Ingelheim Animal Health, Vetoquinol S.A., Ceva Santé Animale, Virbac S.A., PetIQ, Inc., Nestlé Purina PetCare, Hill's Pet Nutrition, PetMed Express, Inc., Covetrus, Inc., Gallant (Gallant Therapeutics), Zenex Animal Health, NOVA Biotechnology and Pharmaceutical Chemistry Institute (Vietnam), TD0015 Herbal Medicine (Vietnamese Traditional Medicine) contribute to innovation, geographic expansion, and service delivery in this space.

Vietnam Companion Animal Osteoarthritis Market Industry Analysis

Growth Drivers

Increasing Pet Ownership:

Vietnam has seen a significant rise in pet ownership, with approximately 9 million households owning pets as of now, according to the Vietnam Pet Association. This trend is driven by urbanization and changing lifestyles, leading to a greater demand for pet healthcare services. The growing number of pets directly correlates with the need for osteoarthritis treatments, as older pets are more susceptible to joint issues, thus expanding the market for related veterinary services and products.

Rising Awareness of Pet Health:

The awareness of pet health has increased markedly, with 75% of pet owners in urban areas acknowledging the importance of regular veterinary check-ups, as reported by the Vietnam Animal Health Association. This shift is fostering a proactive approach to pet care, including the management of conditions like osteoarthritis. As pet owners become more informed, they are more likely to seek specialized treatments, thereby driving demand for osteoarthritis solutions in the companion animal sector.

Advancements in Veterinary Medicine:

The veterinary sector in Vietnam is experiencing rapid advancements, with over 250 veterinary clinics adopting modern diagnostic and treatment technologies in the near future. Innovations such as minimally invasive surgical techniques and advanced imaging are enhancing the treatment of osteoarthritis in pets. These advancements not only improve treatment outcomes but also encourage pet owners to invest in their pets' health, further propelling the market for osteoarthritis-related products and services.

Market Challenges

High Treatment Costs:

The cost of treating osteoarthritis in pets can be prohibitive, with average treatment expenses ranging from 1.8 million to 3.5 million VND per session. This financial barrier limits access to necessary care for many pet owners, particularly in lower-income households. As a result, the high costs associated with effective treatments can hinder market growth, as many pet owners may delay or forgo necessary veterinary care for their animals.

Limited Availability of Specialized Products:

The market for specialized osteoarthritis treatments in Vietnam is still developing, with only a handful of products available. Reports indicate that less than 35% of veterinary clinics stock advanced osteoarthritis medications or supplements. This limited availability restricts treatment options for pet owners and can lead to suboptimal management of the condition, ultimately affecting the overall growth potential of the companion animal osteoarthritis market.

Vietnam Companion Animal Osteoarthritis Market Future Outlook

The future of the Vietnam companion animal osteoarthritis market appears promising, driven by increasing pet ownership and a growing emphasis on pet health. As more pet owners seek preventive care and innovative treatment options, the market is likely to expand. Additionally, the integration of telemedicine in veterinary practices is expected to enhance accessibility to specialized care, allowing for timely interventions. This trend, coupled with the rise of e-commerce for pet products, will further facilitate market growth and improve treatment outcomes for osteoarthritis in pets.

Market Opportunities

Expansion of Veterinary Services:

The expansion of veterinary services, particularly in rural areas, presents a significant opportunity. With over 65% of Vietnam's population living in rural regions, increasing access to veterinary care can enhance the management of osteoarthritis in pets, driving demand for specialized treatments and products.

Development of Innovative Treatment Options:

There is a growing opportunity for the development of innovative treatment options, such as regenerative therapies and personalized medicine. As the market evolves, the introduction of these advanced solutions can meet the rising demand for effective osteoarthritis management, positioning companies favorably within the industry.